Effect of the p53–tristetraprolin–stathmin-1 pathway on trophoblasts at maternal–fetal interface
Xiao-Ling Ma, Xiao-Cui Li, Fu-Ju Tian, Si-Ming Zhang, Xiao-Rui Liu, Yan Zhang, Jian-Xia Fan, Yi Lin
Journal:PLoS One
IF:2.81
DOI:10.1371/journal.pone.0179852
PMID:28658321
Published:2017-06-28
research field:分子生物学细胞生物学妇产科学
Abstract
Problem To reveal the effect of p53–tristetraprolin–stathmin-1 signaling on trophoblasts and recurrent spontaneous abortion (RSA). Method of study Stathmin-1 (STMN1), p53, and tristetraprolin (TTP) expression in paraffin-embedded villus tissue was determined using immunohistochemistry. HTR-8/SVneo cells were treated with doxorubicin to activate p53; STMN1 and TTP levels were detected by quantitative reverse transcription–PCR and western blotting. Western blotting and immunofluorescence were used to investigate STMN1 expression after TTP overexpression or knockdown in HTR-8 cells. Results STMN1 was downregulated and p53 was upregulated in the villus tissue from patients with RSA. Doxorubicin decreased STMN1 expression but enhanced TTP expression in HTR-8 cells. In vitro , TTP overexpression inhibited STMN1 production; TTP knockdown promoted it. TTP downregulated STMN1 expression in trophoblasts by directly binding its 3ʹ untranslated region. Conclusions TTP modulates trophoblast function and interacts with STMN1 and p53, and is related to pregnancy outcomes.
本文使用的Yeasen产品


